CGAS and hepatocellular carcinoma: A combination treatment of cGAMP with PD-L1 inhibitor has shown a more potent antitumor effect in a xenograft model (95), indicating that stimulation of the cGAS-STING pathway may improve immunotherapeutic efficacy for the treatment of HCC.